Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 121 AL 135

PUBMED

Are the effects of community-based dance on Parkinson disease severity, balance, and functional mobility reduced with time? A 2-year prospective pilot study.

Duncan RP, Earhart GM.

J Altern Complement Med. 2014 Oct;20(10):757-63. doi: 10.1089/acm.2012.0774.

0

0

0

PUBMED

Genetic analysis of the fused in sarcoma gene in Chinese Han patients with Parkinson's disease.

Gao K, Zheng W, Deng X, Xiong W, Song Z, Yang Y, Deng H.

Parkinsonism Relat Disord. 2014 Jan;20(1):119-21. doi: 10.1016/j.parkreldis.2013.09.010.

0

0

0

PUBMED

Parkinson's disease patients compensate for balance control asymmetry.

Boonstra TA, Schouten AC, van Vugt JP, Bloem BR, van der Kooij H.

J Neurophysiol. 2014 Dec 15;112(12):3227-39. doi: 10.1152/jn.00813.2013.

0

0

0

PUBMED

Deep brain stimulator-induced diaphoresis in Parkinson's disease patients.

Lam S, Langevin JP, Malkasian D, Gorgulho A, DeSalles A.

J Clin Neurosci. 2014 Apr;21(4):676-8. doi: 10.1016/j.jocn.2013.07.012.

0

0

0

PUBMED

Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration.

Garcia-Martin E, Larrosa JM, Polo V, Satue M, Marques ML, Alarcia R, Seral M, Fuertes I, Otin S, Pablo LE.

Am J Ophthalmol. 2014 Feb;157(2):470-478.e2. doi: 10.1016/j.ajo.2013.09.028.

0

0

0

PUBMED

α-Synuclein ubiquitination and novel therapeutic targets for Parkinson's disease.

Rott R, Szargel R, Shani V, Bisharat S, Engelender S.

CNS Neurol Disord Drug Targets. 2014;13(4):630-7. Review.

0

0

0

PUBMED

Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease.

Darvas M, Henschen CW, Palmiter RD.

Neurobiol Dis. 2014 May;65:112-23. doi: 10.1016/j.nbd.2014.01.017.

0

0

0

PUBMED

Association between PITX3 promoter polymorphism and risk of Parkinson's disease: the impact of ethnicity and onset age.

Qiu G, Fu C, Liang GH.

Neurosci Lett. 2014 Feb 21;561:128-33. doi: 10.1016/j.neulet.2013.12.054.

0

0

0

PUBMED

Application of LSVT BIG intervention to address gait, balance, bed mobility, and dexterity in people with Parkinson disease: a case series.

Janssens J, Malfroid K, Nyffeler T, Bohlhalter S, Vanbellingen T.

Phys Ther. 2014 Jul;94(7):1014-23. doi: 10.2522/ptj.20130232.

0

0

0

PUBMED

Prodromal features for Parkinson's disease--baseline data from the TREND study.

Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B, Lerche S, Eschweiler GW, Maetzler W, Berg D.

Eur J Neurol. 2014 May;21(5):766-72. doi: 10.1111/ene.12382.

0

0

0

PUBMED

Alteration of striatal tetrahydrobiopterin in iron-induced unilateral model of Parkinson's disease.

Aryal B, Lee JK, Kim HR, Kim HG.

Korean J Physiol Pharmacol. 2014 Apr;18(2):129-34. doi: 10.4196/kjpp.2014.18.2.129.

0

0

0

PUBMED

[Comparison of clinical symptoms for Uygur and Han Parkinson's disease patients].

Shang Y, Zhang X, Li Y, Liu Y, Li Y, Xiao Y, Han X, Guo M, Fei L.

Zhonghua Yi Xue Za Zhi. 2014 Jan 7;94(1):31-5. Chinese.

0

0

0

PUBMED

The significance of GBA for Parkinson's disease.

Brockmann K, Berg D.

J Inherit Metab Dis. 2014 Jul;37(4):643-8. doi: 10.1007/s10545-014-9714-7. Review.

0

0

0

PUBMED

Catheter ablation of Wolff-Parkinson-White syndrome in conjoined thoracopagus twins.

Correa R, Lang P, Walsh EP.

Heart Rhythm. 2014 Jun;11(6):1070-2. doi: 10.1016/j.hrthm.2014.03.020. No abstract available.

0

0

0

PUBMED

Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson's disease.

Van Kampen JM, Baranowski D, Kay DG.

PLoS One. 2014 May 7;9(5):e97032. doi: 10.1371/journal.pone.0097032.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy